Clinical Effect of Vesiculating Cupping Therapy Combined with Moxibustion on Bronchial Asthma

Abstract

Background This study aims to investigate clinical effect of vesiculating cupping therapy combined with moxibustion on patients with bronchial asthma. Methods 45 patients with bronchial asthma treated with vesiculating cupping therapy combined with moxibustion in our hospital from March 2022 to March 2023 were selected into observation group, and 45 patients with bronchial asthma treated with moxibustion were selected into control group during the same period. The clinical effects in the two groups were compared, and the changes of TCM symptom score, asthma control, lung function, and inflammatory response before and after treatment were observed. Results The total effective rate of clinical efficacy in observation group was significantly higher than that in control group (P<0.05). After treatment, the levels of TCM symptom score, hypersensitive C-reactive protein, interleukin-6, and tumor necrosis factor-α were obviously reduced in both groups, and these levels in observation group were visibly lower than those in control group (P<0.05). Chinese version of the Children's Asthma Control Test (C-CACT) score, forced expiratory volume in the first second, peak expiratory flow, forced vital capacity, and the predicted percentage of forced expiratory volume in the first second to forced vital capacity were strikingly increased in both groups, and these indexes in observation group were significantly higher than those in control group (P<0.05). Conclusion Vesiculating cupping therapy combined with moxibustion has a good clinical effect in the treatment of patients with bronchial asthma, which has certain effects in alleviating clinical symptoms, improving lung function, and inhibiting inflammatory response.